The hexosamine signaling pathway: O-GlcNAc cycling in feast or famine

Biochimica et Biophysica Acta - General Subjects

Volumn 1800, Issue 2, 2010, Pages 80-95

  Hanover, John A ^a   Krause, Michael W ^a   Love, Dona C ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

AKT; AMPK; Cancer; Cardiovascular disease; Diabetes; Growth factor; Hexosamine; Insulin; MAPK; mTOR; Neurodegeneration; O GlcNAc

Indexed keywords

ACETYLGLUCOSAMINIDASE; ADENYLATE KINASE; HEXOSAMINE; INSULIN; MAMMALIAN TARGET OF RAPAMYCIN; MITOGEN ACTIVATED PROTEIN KINASE; N ACETYLGLUCOSAMINE; N ACETYLGLUCOSAMINYLTRANSFERASE; PROTEASOME; RNA; SERINE; SIRTUIN; THREONINE; URIDINE DIPHOSPHATE N ACETYLGLUCOSAMINE;

ACYLATION; AUTOPHAGY; B LYMPHOCYTE; BIOSYNTHESIS; CAENORHABDITIS ELEGANS; CALORIC RESTRICTION; CARDIOVASCULAR DISEASE; CATABOLISM; CELL MIGRATION; CELL STRESS; CIRCADIAN RHYTHM; DEGENERATIVE DISEASE; DEREGULATION; ENZYME ACTIVITY; GENE INTERACTION; GENETIC TRANSCRIPTION; GROWTH; HOST PATHOGEN INTERACTION; HUMAN; IMMUNOPATHOLOGY; INSULIN RESISTANCE; INVERTEBRATE; LIFESPAN; LYMPHOCYTE ACTIVATION; MALIGNANT NEOPLASTIC DISEASE; MITOCHONDRION; MOLECULAR EVOLUTION; MOLECULAR GENETICS; NERVE DEGENERATION; NEUTROPHIL; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUTRIENT UPTAKE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MODIFICATION; PROTEIN TARGETING; REGULATORY MECHANISM; REVIEW; RNA STABILITY; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

ACETYLGLUCOSAMINE; ACETYLGLUCOSAMINIDASE; ANIMALS; CAENORHABDITIS ELEGANS; CATALYTIC DOMAIN; DIABETES MELLITUS, TYPE 2; EVOLUTION, MOLECULAR; FOOD; GENE EXPRESSION REGULATION; HUMANS; INSULIN RESISTANCE; MAP KINASE SIGNALING SYSTEM; MODELS, ANIMAL; MODELS, MOLECULAR; N-ACETYLGLUCOSAMINYLTRANSFERASES; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTO-ONCOGENE PROTEINS C-AKT; SIRTUINS; STARVATION;

MAMMALIA;

EID: 77949295164     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbagen.2009.07.017     Document Type: Review

References (188)

1. Love D.C., and Hanover J.A. The hexosamine signaling pathway: deciphering the "O-GlcNAc code". Sci. STKE (2005) re13
2. Hart G.W., Housley M.P., and Slawson C. Cycling of O-linked beta-N-acetylglucosamine on nucleocytoplasmic proteins. Nature 446 (2007) 1017-1022
3. Roos M.D., and Hanover J.A. Structure of O-linked GlcNAc transferase: mediator of glycan-dependent signaling. Biochem. Biophys. Res. Commun. 271 (2000) 275-280
4. Banerjee S., Robbins P.W., and Samuelson J. Molecular characterization of nucleocytosolic O-GlcNAc transferases of Giardia lamblia and Cryptosporidium parvum. Glycobiology 19 (2009) 331-336
5. Hanover J.A. Glycan-dependent signaling: O-linked N-acetylglucosamine. FASEB J. 15 (2001) 1865-1876
6. Kamemura K., and Hart G.W. Dynamic interplay between O-glycosylation and O-phosphorylation of nucleocytoplasmic proteins: a new paradigm for metabolic control of signal transduction and transcription. Prog. Nucleic Acid Res. Mol. Biol. 73 (2003) 107-136
7. Vosseller K., Wells L., and Hart G.W. Nucleocytoplasmic O-glycosylation: O-GlcNAc and functional proteomics. Biochimie 83 (2001) 575-581
8. Whelan S.A., and Hart G.W. Identification of O-GlcNAc sites on proteins. Methods Enzymol. 415 (2006) 113-133
9. Zachara N.E. Detecting the "O-GlcNAc-ome"; detection, purification, and analysis of O-GlcNAc modified proteins. Methods Mol. Biol. 534 (2009) 1-30
10. Lehman D.M., Fu D.J., Freeman A.B., Hunt K.J., Leach R.J., Johnson-Pais T., Hamlington J., Dyer T.D., Arya R., Abboud H., Goring H.H., Duggirala R., Blangero J., Konrad R.J., and Stern M.P. A single nucleotide polymorphism in MGEA5 encoding O-GlcNAc-selective N-acetyl-beta-d glucosaminidase is associated with type 2 diabetes in Mexican Americans. Diabetes 54 (2005) 1214-1221
11. Haberhausen G., Schmitt I., Kohler A., Peters U., Rider S., Chelly J., Terwilliger J.D., Monaco A.P., and Muller U. Assignment of the dystonia-parkinsonism syndrome locus, DYT3, to a small region within a 1.8-Mb YAC contig of Xq13.1. Am. J. Hum. Genet. 57 (1995) 644-650
12. Muller U., Haberhausen G., Wagner T., Fairweather N.D., Chelly J., and Monaco A.P. DXS106 and DXS559 flank the X-linked dystonia-parkinsonism syndrome locus (DYT3. Genomics 23 (1994) 114-117
13. Cole R.N., and Hart G.W. Cytosolic O-glycosylation is abundant in nerve terminals. J. Neurochem. 79 (2001) 1080-1089
14. Hanover J.A., Forsythe M.E., Hennessey P.T., Brodigan T.M., Love D.C., Ashwell G., and Krause M. A Caenorhabditis elegans model of insulin resistance: altered macronutrient storage and dauer formation in an OGT-1 knockout. Proc. Natl Acad. Sci. USA 102 (2005) 11266-11271
15. Lazarus B.D., Love D.C., and Hanover J.A. Recombinant O-GlcNAc transferase isoforms: identification of O-GlcNAcase, yes tyrosine kinase, and tau as isoform-specific substrates. Glycobiology 16 (2006) 415-421
16. Lefebvre T., Guinez C., Dehennaut V., Beseme-Dekeyser O., Morelle W., and Michalski J.C. Does O-GlcNAc play a role in neurodegenerative diseases?. Expert Rev. Proteomics 2 (2005) 265-275
17. Marz P., Stetefeld J., Bendfeldt K., Nitsch C., Reinstein J., Shoeman R.L., Dimitriades-Schmutz B., Schwager M., Leiser D., Ozcan S., Otten U., and Ozbek S. Ataxin-10 interacts with O-linked beta-N-acetylglucosamine transferase in the brain. J. Biol. Chem. 281 (2006) 20263-20270
18. Okuyama R., and Marshall S. UDP-N-acetylglucosaminyl transferase (OGT) in brain tissue: temperature sensitivity and subcellular distribution of cytosolic and nuclear enzyme. J. Neurochem. 86 (2003) 1271-1280
19. Rexach J.E., Clark P.M., and Hsieh-Wilson L.C. Chemical approaches to understanding O-GlcNAc glycosylation in the brain. Nat. Chem. Biol. 4 (2008) 97-106
20. Akimoto Y., Hart G.W., Hirano H., and Kawakami H. O-GlcNAc modification of nucleocytoplasmic proteins and diabetes. Med. Mol. Morphol. 38 (2005) 84-91
21. Akimoto Y., Kawakami H., Yamamoto K., Munetomo E., Hida T., and Hirano H. Elevated expression of O-GlcNAc-modified proteins and O-GlcNAc transferase in corneas of diabetic Goto-Kakizaki rats. Invest. Ophthalmol. Vis. Sci. 44 (2003) 3802-3809
22. Lubas W.A., Frank D.W., Krause M., and Hanover J.A. O-Linked GlcNAc transferase is a conserved nucleocytoplasmic protein containing tetratricopeptide repeats. J. Biol. Chem. 272 (1997) 9316-9324
23. McClain D.A., Lubas W.A., Cooksey R.C., Hazel M., Parker G.J., Love D.C., and Hanover J.A. Altered glycan-dependent signaling induces insulin resistance and hyperleptinemia. Proc. Natl. Acad. Sci. USA 99 (2002) 10695-10699
24. Vosseller K., Wells L., Lane M.D., and Hart G.W. Elevated nucleocytoplasmic glycosylation by O-GlcNAc results in insulin resistance associated with defects in Akt activation in 3T3-L1 adipocytes. Proc. Natl. Acad. Sci. USA 99 (2002) 5313-5318
25. Chatham J.C., Not L.G., Fulop N., and Marchase R.B. Hexosamine biosynthesis and protein O-glycosylation: the first line of defense against stress, ischemia, and trauma. Shock 29 (2008) 431-440
26. Fulop N., Marchase R.B., and Chatham J.C. Role of protein O-linked N-acetyl-glucosamine in mediating cell function and survival in the cardiovascular system. Cardiovasc. Res. 73 (2007) 288-297
27. Laczy B., Hill B.G., Wang K., Paterson A.J., White C.R., Xing D., Chen Y.F., Darley-Usmar V., Oparil S., and Chatham J.C. Protein O-GlcNAcylation: a new signaling paradigm for the cardiovascular system. Am. J. Physiol., Heart Circ. Physiol. 296 (2009) H13-H28
28. Clark R.J., McDonough P.M., Swanson E., Trost S.U., Suzuki M., Fukuda M., and Dillmann W.H. Diabetes and the accompanying hyperglycemia impairs cardiomyocyte calcium cycling through increased nuclear O-GlcNAcylation. J. Biol. Chem. 278 (2003) 44230-44237
29. Ngoh G.A., Facundo H.T., Hamid T., Dillmann W., Zachara N.E., and Jones S.P. Unique hexosaminidase reduces metabolic survival signal and sensitizes cardiac myocytes to hypoxia/reoxygenation injury. Circ. Res. 104 (2009) 41-49
30. Ngoh G.A., Watson L.J., Facundo H.T., Dillmann W., and Jones S.P. Non-canonical glycosyltransferase modulates post-hypoxic cardiac myocyte death and mitochondrial permeability transition. J. Mol. Cell. Cardiol. 45 (2008) 313-325
31. Golks A., and Guerini D. The O-linked N-acetylglucosamine modification in cellular signalling and the immune system. 'Protein modifications: beyond the usual suspects' review series. EMBO Rep. 9 (2008) 748-753
32. Golks A., Tran T.T., Goetschy J.F., and Guerini D. Requirement for O-linked N-acetylglucosaminyltransferase in lymphocytes activation. EMBO J. 26 (2007) 4368-4379
33. Kreppel L.K., Blomberg M.A., and Hart G.W. Dynamic glycosylation of nuclear and cytosolic proteins. Cloning and characterization of a unique O-GlcNAc transferase with multiple tetratricopeptide repeats. J. Biol. Chem. 272 (1997) 9308-9315
34. Jacobsen S.E., Binkowski K.A., and Olszewski N.E. SPINDLY, a tetratricopeptide repeat protein involved in gibberellin signal transduction in Arabidopsis. Proc. Natl. Acad. Sci. USA 93 (1996) 9292-9296
35. Gao Y., Wells L., Comer F.I., Parker G.J., and Hart G.W. Dynamic O-glycosylation of nuclear and cytosolic proteins: cloning and characterization of a neutral, cytosolic beta-N-acetylglucosaminidase from human brain. J. Biol. Chem. 276 (2001) 9838-9845
36. Heckel D., Comtesse N., Brass N., Blin N., Zang K.D., and Meese E. Novel immunogenic antigen homologous to hyaluronidase in meningioma. Hum. Mol. Genet. 7 (1998) 1859-1872
37. Nolte D., and Muller U. Human O-GlcNAc transferase (OGT): genomic structure, analysis of splice variants, fine mapping in Xq13.1. Mamm. Genome 13 (2002) 62-64
38. Shafi R., Iyer S.P., Ellies L.G., O'Donnell N., Marek K.W., Chui D., Hart G.W., and Marth J.D. The O-GlcNAc transferase gene resides on the X chromosome and is essential for embryonic stem cell viability and mouse ontogeny. Proc. Natl. Acad. Sci. USA 97 (2000) 5735-5739
39. Hanover J.A., Lai Z., Lee G., Lubas W.A., and Sato S.M. Elevated O-linked N-acetylglucosamine metabolism in pancreatic beta-cells. Arch. Biochem. Biophys. 362 (1999) 38-45
40. Love D.C., Kochan J., Cathey R.L., Shin S.H., and Hanover J.A. Mitochondrial and nucleocytoplasmic targeting of O-linked GlcNAc transferase. J. Cell Sci. 116 (2003) 647-654
41. Lazarus B.D., Roos M.D., and Hanover J.A. Mutational analysis of the catalytic domain of O-linked N-acetylglucosaminyl transferase. J. Biol. Chem. 280 (2005) 35537-35544
42. Lubas W.A., and Hanover J.A. Functional expression of O-linked GlcNAc transferase. Domain structure and substrate specificity. J. Biol. Chem. 275 (2000) 10983-10988
43. Hartweck L.M., Genger R.K., Grey W.M., and Olszewski N.E. SECRET AGENT and SPINDLY have overlapping roles in the development of Arabidopsis thaliana L. Heyn. J. Exp. Bot. 57 (2006) 865-875
44. Hartweck L.M., Scott C.L., and Olszewski N.E. Two O-linked N-acetylglucosamine transferase genes of Arabidopsis thaliana L. Heynh. have overlapping functions necessary for gamete and seed development. Genetics 161 (2002) 1279-1291
45. Jinek M., Rehwinkel J., Lazarus B.D., Izaurralde E., Hanover J.A., and Conti E. The superhelical TPR-repeat domain of O-linked GlcNAc transferase exhibits structural similarities to importin alpha. Nat. Struct. Mol. Biol. 11 (2004) 1001-1007
46. Martinez-Fleites C., Macauley M.S., He Y., Shen D.L., Vocadlo D.J., and Davies G.J. Structure of an O-GlcNAc transferase homolog provides insight into intracellular glycosylation. Nat. Struct. Mol. Biol. 15 (2008) 764-765
47. Clarke A.J., Hurtado-Guerrero R., Pathak S., Schuttelkopf A.W., Borodkin V., Shepherd S.M., Ibrahim A.F., and van Aalten D.M. Structural insights into mechanism and specificity of O-GlcNAc transferase. EMBO J. 27 (2008) 2780-2788
48. Kreppel L.K., and Hart G.W. Regulation of a cytosolic and nuclear O-GlcNAc transferase. Role of the tetratricopeptide repeats. J. Biol. Chem. 274 (1999) 32015-32022
49. Schultz J., and Pils B. Prediction of structure and functional residues for O-GlcNAcase, a divergent homologue of acetyltransferases. FEBS Lett. 529 (2002) 179-182
50. Toleman C., Paterson A.J., and Kudlow J.E. Location and characterization of the O-GlcNAcase active site. Biochim. Biophys. Acta 1760 (2006) 829-839
51. Kim E.J., Kang D.O., Love D.C., and Hanover J.A. Enzymatic characterization of O-GlcNAcase isoforms using a fluorogenic GlcNAc substrate. Carbohydr. Res. 341 (2006) 971-982
52. Toleman C., Paterson A.J., Whisenhunt T.R., and Kudlow J.E. Characterization of the histone acetyltransferase (HAT) domain of a bifunctional protein with activable O-GlcNAcase and HAT activities. J. Biol. Chem. 279 (2004) 53665-53673
53. Whisenhunt T.R., Yang X., Bowe D.B., Paterson A.J., Van Tine B.A., and Kudlow J.E. Disrupting the enzyme complex regulating O-GlcNAcylation blocks signaling and development. Glycobiology 16 (2006) 551-563
54. Rao F.V., Dorfmueller H.C., Villa F., Allwood M., Eggleston I.M., and van Aalten D.M. Structural insights into the mechanism and inhibition of eukaryotic O-GlcNAc hydrolysis. EMBO J. 25 (2006) 1569-1578
55. Dennis R.J., Taylor E.J., Macauley M.S., Stubbs K.A., Turkenburg J.P., Hart S.J., Black G.N., Vocadlo D.J., and Davies G.J. Structure and mechanism of a bacterial beta-glucosaminidase having O-GlcNAcase activity. Nat. Struct. Mol. Biol. 13 (2006) 365-371
56. Macauley M.S., Whitworth G.E., Debowski A.W., Chin D., and Vocadlo D.J. O-GlcNAcase uses substrate-assisted catalysis: kinetic analysis and development of highly selective mechanism-inspired inhibitors. J. Biol. Chem. 280 (2005) 25313-25322
57. Lin Y., Fletcher C.M., Zhou J., Allis C.D., and Wagner G. Solution structure of the catalytic domain of GCN5 histone acetyltransferase bound to coenzyme A. Nature 400 (1999) 86-89
58. Holt G.D., and Hart G.W. The subcellular distribution of terminal N-acetylglucosamine moieties. Localization of a novel protein-saccharide linkage, O-linked GlcNAc. J. Biol. Chem. 261 (1986) 8049-8057
59. Hanover J.A., Cohen C.K., Willingham M.C., and Park M.K. O-linked N-acetylglucosamine is attached to proteins of the nuclear pore. Evidence for cytoplasmic and nucleoplasmic glycoproteins. J. Biol. Chem. 262 (1987) 9887-9894
60. Park M.K., D'Onofrio M., Willingham M.C., and Hanover J.A. A monoclonal antibody against a family of nuclear pore proteins (nucleoporins): O-linked N-acetylglucosamine is part of the immunodeterminant. Proc. Natl. Acad. Sci. USA 84 (1987) 6462-6466
61. Holt G.D., Snow C.M., Senior A., Haltiwanger R.S., Gerace L., and Hart G.W. Nuclear pore complex glycoproteins contain cytoplasmically disposed O-linked N-acetylglucosamine. J. Cell Biol. 104 (1987) 1157-1164
62. Snow C.M., Senior A., and Gerace L. Monoclonal antibodies identify a group of nuclear pore complex glycoproteins. J. Cell Biol. 104 (1987) 1143-1156
63. Hanover J.A., Yu S., Lubas W.B., Shin S.H., Ragano-Caracciola M., Kochran J., and Love D.C. Mitochondrial and nucleocytoplasmic isoforms of O-linked GlcNAc transferase encoded by a single mammalian gene. Arch. Biochem. Biophys. 409 (2003) 287-297
64. Fletcher B.S., Dragstedt C., Notterpek L., and Nolan G.P. Functional cloning of SPIN-2, a nuclear anti-apoptotic protein with roles in cell cycle progression. Leukemia 16 (2002) 1507-1518
65. Arvanitis D.L., Arvanitis L.D., Panourias I.G., Kitsoulis P., and Kanavaros P. Mitochondria-rich normal, metaplastic, and neoplastic cells show overexpression of the epitope H recognized by the monoclonal antibody H. Pathol. Res. Pract. 201 (2005) 319-324
66. Champattanachai V., Marchase R.B., and Chatham J.C. Glucosamine protects neonatal cardiomyocytes from ischemia-reperfusion injury via increased protein O-GlcNAc and increased mitochondrial Bcl-2. Am. J. Physiol., Cell Physiol. 294 (2008) C1509-C1520
67. Hu Y., Suarez J., Fricovsky E., Wang H., Scott B.T., Trauger S.A., Han W., Hu Y., Oyeleye M.O., and Dillmann W.H. Increased enzymatic O-GlcNAcylation of mitochondrial proteins impairs mitochondrial function in cardiac myocytes exposed to high glucose. J. Biol. Chem. 284 (2009) 547-555
68. Jones S.P., Zachara N.E., Ngoh G.A., Hill B.G., Teshima Y., Bhatnagar A., Hart G.W., and Marban E. Cardioprotection by N-acetylglucosamine linkage to cellular proteins. Circulation 117 (2008) 1172-1182
69. Suarez J., Hu Y., Makino A., Fricovsky E., Wang H., and Dillmann W.H. Alterations in mitochondrial function and cytosolic calcium induced by hyperglycemia are restored by mitochondrial transcription factor A in cardiomyocytes. Am. J. Physiol., Cell Physiol. 295 (2008) C1561-C1568
70. Comtesse N., Maldener E., and Meese E. Identification of a nuclear variant of MGEA5, a cytoplasmic hyaluronidase and a beta-N-acetylglucosaminidase. Biochem. Biophys. Res. Commun. 283 (2001) 634-640
71. Gross B.J., Kraybill B.C., and Walker S. Discovery of O-GlcNAc transferase inhibitors. J. Am. Chem. Soc. 127 (2005) 14588-14589
72. Kim E.J., Amorelli B., Abdo M., Thomas C.J., Love D.C., Knapp S., and Hanover J.A. Distinctive inhibition of O-GlcNAcase isoforms by an alpha-GlcNAc thiolsulfonate. J. Am. Chem. Soc. 129 (2007) 14854-14855
73. Vocadlo D.J., Hang H.C., Kim E.J., Hanover J.A., and Bertozzi C.R. A chemical approach for identifying O-GlcNAc-modified proteins in cells. Proc. Natl. Acad. Sci. USA 100 (2003) 9116-9121
74. Forsythe M.E., Love D.C., Lazarus B.D., Kim E.J., Prinz W.A., Ashwell G., Krause M.W., and Hanover J.A. Caenorhabditis elegans ortholog of a diabetes susceptibility locus: oga-1 (O-GlcNAcase) knockout impacts O-GlcNAc cycling, metabolism, and dauer. Proc. Natl. Acad. Sci. USA 103 (2006) 11952-11957
75. Butkinaree C., Cheung W.D., Park S., Park K., Barber M., and Hart G.W. Characterization of beta-N-acetylglucosaminidase cleavage by caspase-3 during apoptosis. J. Biol. Chem. 283 (2008) 23557-23566
76. Macauley M.S., and Vocadlo D.J. Enzymatic characterization and inhibition of the nuclear variant of human O-GlcNAcase. Carbohydr. Res. 344 (2009) 1079-1084
77. Kim E.J., Perreira M., Thomas C.J., and Hanover J.A. An O-GlcNAcase-specific inhibitor and substrate engineered by the extension of the N-acetyl moiety. J. Am. Chem. Soc. 128 (2006) 4234-4235
78. Dehennaut V., Lefebvre T., Sellier C., Leroy Y., Gross B., Walker S., Cacan R., Michalski J.C., Vilain J.P., and Bodart J.F. O-linked N-acetylglucosaminyltransferase inhibition prevents G2/M transition in Xenopus laevis oocytes. J. Biol. Chem. 282 (2007) 12527-12536
79. Lameira J., Alves C.N., Moliner V., Marti S., Kanaan N., and Tunon I. A quantum mechanics/molecular mechanics study of the protein-ligand interaction of two potent inhibitors of human O-GlcNAcase: PUGNAc and NAG-thiazoline. J. Phys. Chem., B 112 (2008) 14260-14266
80. Macauley M.S., Bubb A.K., Martinez-Fleites C., Davies G.J., and Vocadlo D.J. Elevation of global O-GlcNAc levels in 3T3-L1 adipocytes by selective inhibition of O-GlcNAcase does not induce insulin resistance. J. Biol. Chem. 283 (2008) 34687-34695
81. Pathak S., Dorfmueller H.C., Borodkin V.S., and van Aalten D.M. Chemical dissection of the link between streptozotocin, O-GlcNAc, and pancreatic cell death. Chem. Biol. 15 (2008) 799-807
82. Stubbs K.A., Zhang N., and Vocadlo D.J. A divergent synthesis of 2-acyl derivatives of PUGNAc yields selective inhibitors of O-GlcNAcase. Org. Biomol. Chem. 4 (2006) 839-845
83. Whitworth G.E., Macauley M.S., Stubbs K.A., Dennis R.J., Taylor E.J., Davies G.J., Greig I.R., and Vocadlo D.J. Analysis of PUGNAc and NAG-thiazoline as transition state analogues for human O-GlcNAcase: mechanistic and structural insights into inhibitor selectivity and transition state poise. J. Am. Chem. Soc. 129 (2007) 635-644
84. Yuzwa S.A., Macauley M.S., Heinonen J.E., Shan X., Dennis R.J., He Y., Whitworth G.E., Stubbs K.A., McEachern E.J., Davies G.J., and Vocadlo D.J. A potent mechanism-inspired O-GlcNAcase inhibitor that blocks phosphorylation of tau in vivo. Nat. Chem. Biol. 4 (2008) 483-490
85. Cheung W.D., Sakabe K., Housley M.P., Dias W.B., and Hart G.W. O-linked beta-N-acetylglucosaminyltransferase substrate specificity is regulated by myosin phosphatase targeting and other interacting proteins. J. Biol. Chem. 283 (2008) 33935-33941
86. Iyer S.P., Akimoto Y., and Hart G.W. Identification and cloning of a novel family of coiled-coil domain proteins that interact with O-GlcNAc transferase. J. Biol. Chem. 278 (2003) 5399-5409
87. Yang X., Zhang F., and Kudlow J.E. Recruitment of O-GlcNAc transferase to promoters by corepressor mSin3A: coupling protein O-GlcNAcylation to transcriptional repression. Cell 110 (2002) 69-80
88. Wysocka J., Myers M.P., Laherty C.D., Eisenman R.N., and Herr W. Human Sin3 deacetylase and trithorax-related Set1/Ash2 histone H3-K4 methyltransferase are tethered together selectively by the cell-proliferation factor HCF-1. Genes Dev. 17 (2003) 896-911
89. Mendjan S., Taipale M., Kind J., Holz H., Gebhardt P., Schelder M., Vermeulen M., Buscaino A., Duncan K., Mueller J., Wilm M., Stunnenberg H.G., Saumweber H., and Akhtar A. Nuclear pore components are involved in the transcriptional regulation of dosage compensation in Drosophila. Mol. Cell 21 (2006) 811-823
90. Wells L., Kreppel L.K., Comer F.I., Wadzinski B.E., and Hart G.W. O-GlcNAc transferase is in a functional complex with protein phosphatase 1 catalytic subunits. J. Biol. Chem. 279 (2004) 38466-38470
91. Fujiki R., Chikanishi T., Hashiba W., Ito H., Takada I., Roeder R.G., Kitagawa H., and Kato S. GlcNAcylation of a histone methyltransferase in retinoic-acid-induced granulopoiesis. Nature 459 (2009) 455-459
92. Li S., Armstrong C.M., Bertin N., Ge H., Milstein S., Boxem M., Vidalain P.O., Han J.D., Chesneau A., Hao T., Goldberg D.S., Li N., Martinez M., Rual J.F., Lamesch P., Xu L., Tewari M., Wong S.L., Zhang L.V., Berriz G.F., Jacotot L., Vaglio P., Reboul J., Hirozane-Kishikawa T., Li Q., Gabel H.W., Elewa A., Baumgartner B., Rose D.J., Yu H., Bosak S., Sequerra R., Fraser A., Mango S.E., Saxton W.M., Strome S., Van Den Heuvel S., Piano F., Vandenhaute J., Sardet C., Gerstein M., Doucette-Stamm L., Gunsalus K.C., Harper J.W., Cusick M.E., Roth F.P., Hill D.E., and Vidal M. A map of the interactome network of the metazoan C. elegans. Science 303 (2004) 540-543
93. Cheung W.D., and Hart G.W. AMP-activated protein kinase and p38 MAPK activate O-GlcNAcylation of neuronal proteins during glucose deprivation. J. Biol. Chem. 283 (2008) 13009-13020
94. Giot L., Bader J.S., Brouwer C., Chaudhuri A., Kuang B., Li Y., Hao Y.L., Ooi C.E., Godwin B., Vitols E., Vijayadamodar G., Pochart P., Machineni H., Welsh M., Kong Y., Zerhusen B., Malcolm R., Varrone Z., Collis A., Minto M., Burgess S., McDaniel L., Stimpson E., Spriggs F., Williams J., Neurath K., Ioime N., Agee M., Voss E., Furtak K., Renzulli R., Aanensen N., Carrolla S., Bickelhaupt E., Lazovatsky Y., DaSilva A., Zhong J., Stanyon C.A., Finley R.L.J., White K.P., Braverman M., Jarvie T., Gold S., Leach M., Knight J., Shimkets R.A., McKenna M.P., Chant J., and Rothberg J.M. A protein interaction map of Drosophila melanogaster. Science 302 (2003) 1727-1736
95. Marshall S., Bacote V., and Traxinger R.R. Complete inhibition of glucose-induced desensitization of the glucose transport system by inhibitors of mRNA synthesis. Evidence for rapid turnover of glutamine:fructose-6-phosphate amidotransferase. J. Biol. Chem. 266 (1991) 10155-10161
96. Marshall S., Bacote V., and Traxinger R.R. Discovery of a metabolic pathway mediating glucose-induced desensitization of the glucose transport system. Role of hexosamine biosynthesis in the induction of insulin resistance. J. Biol. Chem. 266 (1991) 4706-4712
97. Marshall S., Garvey W.T., and Traxinger R.R. New insights into the metabolic regulation of insulin action and insulin resistance: role of glucose and amino acids. FASEB J. 5 (1991) 3031-3036
98. Mendelsohn R., Cheung P., Berger L., Partridge E., Lau K., Datti A., Pawling J., and Dennis J.W. Complex N-glycan and metabolic control in tumor cells. Cancer Res. 67 (2007) 9771-9780
99. Ohtsubo K., Takamatsu S., Minowa M.T., Yoshida A., Takeuchi M., and Marth J.D. Dietary and genetic control of glucose transporter 2 glycosylation promotes insulin secretion in suppressing diabetes. Cell 123 (2005) 1307-1321
100. Akimoto Y., Hart G.W., Wells L., Vosseller K., Yamamoto K., Munetomo E., Ohara-Imaizumi M., Nishiwaki C., Nagamatsu S., Hirano H., and Kawakami H. Elevation of the post-translational modification of proteins by O-linked N-acetylglucosamine leads to deterioration of the glucose-stimulated insulin secretion in the pancreas of diabetic Goto-Kakizaki rats. Glycobiology 17 (2007) 127-140
101. Arias E.B., Kim J., and Cartee G.D. Prolonged incubation in PUGNAc results in increased protein O-linked glycosylation and insulin resistance in rat skeletal muscle. Diabetes 53 (2004) 921-930
102. Ball L.E., Berkaw M.N., and Buse M.G. Identification of the major site of O-linked beta-N-acetylglucosamine modification in the C terminus of insulin receptor substrate-1. Mol. Cell. Proteomics 5 (2006) 313-323
103. Buse M.G. Hexosamines, insulin resistance, and the complications of diabetes: current status. Am. J. Physiol., Endocrinol. Metab. 290 (2006) E1-E8
104. Copeland R.J., Bullen J.W., and Hart G.W. Cross-talk between GlcNAcylation and phosphorylation: roles in insulin resistance and glucose toxicity. Am. J. Physiol., Endocrinol. Metab. 295 (2008) E17-E28
105. Matthews J.A., Belof J.L., Acevedo-Duncan M., and Potter R.L. Glucosamine-induced increase in Akt phosphorylation corresponds to increased endoplasmic reticulum stress in astroglial cells. Mol. Cell. Biochem. 298 (2007) 109-123
106. Parker G.J., Lund K.C., Taylor R.P., and McClain D.A. Insulin resistance of glycogen synthase mediated by o-linked N-acetylglucosamine. J. Biol. Chem. 278 (2003) 10022-10027
107. Walgren J.L., Vincent T.S., Schey K.L., and Buse M.G. High glucose and insulin promote O-GlcNAc modification of proteins, including alpha-tubulin. Am. J. Physiol., Endocrinol. Metab. 284 (2003) E424-E434
108. Wells L., Vosseller K., and Hart G.W. A role for N-acetylglucosamine as a nutrient sensor and mediator of insulin resistance. Cell. Mol. Life Sci. 60 (2003) 222-228
109. Yang X., Ongusaha P.P., Miles P.D., Havstad J.C., Zhang F., So W.V., Kudlow J.E., Michell R.H., Olefsky J.M., Field S.J., and Evans R.M. Phosphoinositide signalling links O-GlcNAc transferase to insulin resistance. Nature 451 (2008) 964-969
110. Hebert L.F.J., Daniels M.C., Zhou J., Crook E.D., Turner R.L., Simmons S.T., Neidigh J.L., Zhu J.S., Baron A.D., and McClain D.A. Overexpression of glutamine:fructose-6-phosphate amidotransferase in transgenic mice leads to insulin resistance. J. Clin. Invest. 98 (1996) 930-936
111. McClain D.A., Alexander T., Cooksey R.C., and Considine R.V. Hexosamines stimulate leptin production in transgenic mice. Endocrinology 141 (2000) 1999-2002
112. Veerababu G., Tang J., Hoffman R.T., Daniels M.C., Hebert L.F.J., Crook E.D., Cooksey R.C., and McClain D.A. Overexpression of glutamine: fructose-6-phosphate amidotransferase in the liver of transgenic mice results in enhanced glycogen storage, hyperlipidemia, obesity, and impaired glucose tolerance. Diabetes 49 (2000) 2070-2078
113. Cooksey R.C., and McClain D.A. Transgenic mice overexpressing the rate-limiting enzyme for hexosamine synthesis in skeletal muscle or adipose tissue exhibit total body insulin resistance. Ann. N.Y. Acad. Sci. 967 (2002) 102-111
114. Boehmelt G., Wakeham A., Elia A., Sasaki T., Plyte S., Potter J., Yang Y., Tsang E., Ruland J., Iscove N.N., Dennis J.W., and Mak T.W. Decreased UDP-GlcNAc levels abrogate proliferation control in EMeg32-deficient cells. EMBO J. 19 (2000) 5092-5104
115. O'Donnell N., Zachara N.E., Hart G.W., and Marth J.D. Ogt-dependent X-chromosome-linked protein glycosylation is a requisite modification in somatic cell function and embryo viability. Mol. Cell. Biol. 24 (2004) 1680-1690
116. Clancy D.J., Gems D., Harshman L.G., Oldham S., Stocker H., Hafen E., Leevers S.J., and Partridge L. Extension of life-span by loss of CHICO, a Drosophila insulin receptor substrate protein. Science 292 (2001) 104-106
117. Finch C.E., and Ruvkun G. The genetics of aging. Annu. Rev. Genomics Hum. Genet. 2 (2001) 435-462
118. Lin K., Hsin H., Libina N., and Kenyon C. Regulation of the Caenorhabditis elegans longevity protein DAF-16 by insulin/IGF-1 and germline signaling. Nat. Genet. 28 (2001) 139-145
119. Paradis S., and Ruvkun G. Caenorhabditis elegans Akt/PKB transduces insulin receptor-like signals from AGE-1 PI3 kinase to the DAF-16 transcription factor. Genes Dev. 12 (1998) 2488-2498
120. Pierce S.B., Costa M., Wisotzkey R., Devadhar S., Homburger S.A., Buchman A.R., Ferguson K.C., Heller J., Platt D.M., Pasquinelli A.A., Liu L.X., Doberstein S.K., and Ruvkun G. Regulation of DAF-2 receptor signaling by human insulin and ins-1, a member of the unusually large and diverse C. elegans insulin gene family. Genes Dev. 15 (2001) 672-686
121. Tissenbaum H.A., and Ruvkun G. An insulin-like signaling pathway affects both longevity and reproduction in Caenorhabditis elegans. Genetics 148 (1998) 703-717
122. Wolkow C.A., Kimura K.D., Lee M.S., and Ruvkun G. Regulation of C. elegans life-span by insulinlike signaling in the nervous system. Science 290 (2000) 147-150
123. Gami M.S., and Wolkow C.A. Studies of Caenorhabditis elegans DAF-2/insulin signaling reveal targets for pharmacological manipulation of lifespan. Aging Cell 5 (2006) 31-37
124. Taguchi A., and White M.F. Insulin-like signaling, nutrient homeostasis, and life span. Annu. Rev. Physiol. 70 (2008) 191-212
125. Gambetta M.C., Oktaba K., and Muller J. Essential role of the glycosyltransferase Sxc/Ogt in polycomb repression. Science (2009)
126. Ingham P.W. A gene that regulates the bithorax complex differentially in larval and adult cells of Drosophila. Cell 37 (1984) 815-823
127. Bellen H.J., Levis R.W., Liao G., He Y., Carlson J.W., Tsang G., Evans-Holm M., Hiesinger P.R., Schulze K.L., Rubin G.M., Hoskins R.A., and Spradling A.C. The BDGP gene disruption project: single transposon insertions associated with 40% of Drosophila genes. Genetics 167 (2004) 761-781
128. Patterson G.I., and Padgett R.W. TGF beta-related pathways. Roles in Caenorhabditis elegans development. Trends Genet. 16 (2000) 27-33
129. Berman K., McKay J., Avery L., and Cobb M. Isolation and characterization of pmk-(1-3): three p38 homologs in Caenorhabditis elegans. Mol. Cell. Biol. Res. Commun. 4 (2001) 337-344
130. Byrne A.B., Weirauch M.T., Wong V., Koeva M., Dixon S.J., Stuart J.M., and Roy P.J. A global analysis of genetic interactions in Caenorhabditis elegans. J. Biol. 6 (2007) 8
131. Sayat R., Leber B., Grubac V., Wiltshire L., and Persad S. O-GlcNAc-glycosylation of beta-catenin regulates its nuclear localization and transcriptional activity. Exp. Cell Res. 314 (2008) 2774-2787
132. Hanover J.A., Love D.C., and Prinz W.A. Calmodulin-driven nuclear entry: trigger for sex determination and terminal differentiation. J. Biol. Chem. (2009)
133. Wang Z., Gucek M., and Hart G.W. Cross-talk between GlcNAcylation and phosphorylation: site-specific phosphorylation dynamics in response to globally elevated O-GlcNAc. Proc. Natl. Acad. Sci. USA 105 (2008) 13793-13798
134. Ande S.R., Moulik S., and Mishra S. Interaction between O-GlcNAc modification and tyrosine phosphorylation of prohibitin: implication for a novel binary switch. PLoS ONE 4 (2009) e4586
135. Housley M.P., Udeshi N.D., Rodgers J.T., Shabanowitz J., Puigserver P., Hunt D.F., and Hart G.W. A PGC-1{alpha}-O-GlcNAc transferase complex regulates FoxO transcription factor activity in response to glucose. J. Biol. Chem. 284 (2009) 5148-5157
136. Dentin R., Hedrick S., Xie J., Yates III J., and Montminy M. Hepatic glucose sensing via the CREB coactivator CRTC2. Science 319 (2008) 1402-1405
137. Gwinn D.M., Shackelford D.B., Egan D.F., Mihaylova M.M., Mery A., Vasquez D.S., Turk B.E., and Shaw R.J. AMPK phosphorylation of raptor mediates a metabolic checkpoint. Mol. Cell 30 (2008) 214-226
138. Hardie D.G. AMPK and Raptor: matching cell growth to energy supply. Mol. Cell 30 (2008) 263-265
139. Sarbassov D.D., Ali S.M., and Sabatini D.M. Growing roles for the mTOR pathway. Curr. Opin. Cell Biol. 17 (2005) 596-603
140. Pouyssegur J., Dayan F., and Mazure N.M. Hypoxia signalling in cancer and approaches to enforce tumour regression. Nature 441 (2006) 437-443
141. Luo B., Parker G.J., Cooksey R.C., Soesanto Y., Evans M., Jones D., and McClain D.A. Chronic hexosamine flux stimulates fatty acid oxidation by activating AMP-activated protein kinase in adipocytes. J. Biol. Chem. 282 (2007) 7172-7180
142. Narbonne P., and Roy R. Inhibition of germline proliferation during C. elegans dauer development requires PTEN, LKB1 and AMPK signalling. Development 133 (2006) 611-619
143. Dehennaut V., Slomianny M.C., Page A., Vercoutter-Edouart A.S., Jessus C., Michalski J.C., Vilain J.P., Bodart J.F., and Lefebvre T. Identification of structural and functional O-linked N-acetylglucosamine-bearing proteins in Xenopus laevis oocyte. Mol. Cell. Proteomics 7 (2008) 2229-2245
144. Chakraborty A., Saha D., Bose A., Chatterjee M., and Gupta N.K. Regulation of eIF-2 alpha-subunit phosphorylation in reticulocyte lysate. Biochemistry 33 (1994) 6700-6706
145. Nandi A., Sprung R., Barma D.K., Zhao Y., Kim S.C., Falck J.R., and Zhao Y. Global identification of O-GlcNAc-modified proteins. Anal. Chem. 78 (2006) 452-458
146. Ohn T., Kedersha N., Hickman T., Tisdale S., and Anderson P. A functional RNAi screen links O-GlcNAc modification of ribosomal proteins to stress granule and processing body assembly. Nat. Cell Biol. 10 (2008) 1224-1231
147. Berdichevsky A., and Guarente L. A stress response pathway involving sirtuins, forkheads and 14-3-3 proteins. Cell Cycle 5 (2006) 2588-2591
148. Longo V.D. Linking sirtuins, IGF-I signaling, and starvation. Exp. Gerontol. 44 (2009) 70-74
149. Saunders L.R., and Verdin E. Sirtuins: critical regulators at the crossroads between cancer and aging. Oncogene 26 (2007) 5489-5504
150. Westphal C.H., Dipp M.A., and Guarente L. A therapeutic role for sirtuins in diseases of aging?. Trends Biochem. Sci. 32 (2007) 555-560
151. Liu Y., Dentin R., Chen D., Hedrick S., Ravnskjaer K., Schenk S., Milne J., Meyers D.J., Cole P., Yates J.R., Olefsky J., Guarente L., and Montminy M. A fasting inducible switch modulates gluconeogenesis via activator/coactivator exchange. Nature 456 (2008) 269-273
152. Du X.L., Edelstein D., Dimmeler S., Ju Q., Sui C., and Brownlee M. Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site. J. Clin. Invest. 108 (2001) 1341-1348
153. Musicki B., Kramer M.F., Becker R.E., and Burnett A.L. Inactivation of phosphorylated endothelial nitric oxide synthase (Ser-1177) by O-GlcNAc in diabetes-associated erectile dysfunction. Proc. Natl. Acad. Sci. USA 102 (2005) 11870-11875
154. Brickley K., Smith M.J., Beck M., and Stephenson F.A. GRIF-1 and OIP106, members of a novel gene family of coiled-coil domain proteins: association in vivo and in vitro with kinesin. J. Biol. Chem. 280 (2005) 14723-14732
155. MacAskill A.F., Brickley K., Stephenson F.A., and Kittler J.T. GTPase dependent recruitment of Grif-1 by Miro1 regulates mitochondrial trafficking in hippocampal neurons. Mol. Cell. Neurosci. 40 (2009) 301-312
156. Smith M.J., Pozo K., Brickley K., and Stephenson F.A. Mapping the GRIF-1 binding domain of the kinesin, KIF5C, substantiates a role for GRIF-1 as an adaptor protein in the anterograde trafficking of cargoes. J. Biol. Chem. 281 (2006) 27216-27228
157. Beck M., Brickley K., Wilkinson H.L., Sharma S., Smith M., Chazot P.L., Pollard S., and Stephenson F.A. Identification, molecular cloning, and characterization of a novel GABAA receptor-associated protein, GRIF-1. J. Biol. Chem. 277 (2002) 30079-30090
158. Pozo K., and Stephenson F.A. GRIF-1-kinesin-1 interactions: a confocal microscopy study. Biochem. Soc. Trans. 34 (2006) 48-50
159. Rice S.E., and Gelfand V.I. Paradigm lost: milton connects kinesin heavy chain to miro on mitochondria. J. Cell Biol. 173 (2006) 459-461
160. Stowers R.S., Megeath L.J., Gorska-Andrzejak J., Meinertzhagen I.A., and Schwarz T.L. Axonal transport of mitochondria to synapses depends on milton, a novel Drosophila protein. Neuron 36 (2002) 1063-1077
161. Stuart L.M., Boulais J., Charriere G.M., Hennessy E.J., Brunet S., Jutras I., Goyette G., Rondeau C., Letarte S., Huang H., Ye P., Morales F., Kocks C., Bader J.S., Desjardins M., and Ezekowitz R.A. A systems biology analysis of the Drosophila phagosome. Nature 445 (2007) 95-101
162. Kirk E., Chin L.S., and Li L. GRIF1 binds Hrs and is a new regulator of endosomal trafficking. J. Cell Sci. 119 (2006) 4689-4701
163. Webber E., Li L., and Chin L.S. Hypertonia-associated protein Trak1 is a novel regulator of endosome-to-lysosome trafficking. J. Mol. Biol. 382 (2008) 638-651
164. Bowe D.B., Sadlonova A., Toleman C.A., Novak Z., Hu Y., Huang P., Mukherjee S., Whitsett T., Frost A.R., Paterson A.J., and Kudlow J.E. O-GlcNAc integrates the proteasome and transcriptome to regulate nuclear hormone receptors. Mol. Cell. Biol. 26 (2006) 8539-8550
165. Guinez C., Mir A.M., Dehennaut V., Cacan R., Harduin-Lepers A., Michalski J.C., and Lefebvre T. Protein ubiquitination is modulated by O-GlcNAc glycosylation. FASEB J. 22 (2008) 2901-2911
166. Han I., and Kudlow J.E. Reduced O glycosylation of Sp1 is associated with increased proteasome susceptibility. Mol. Cell. Biol. 17 (1997) 2550-2558
167. Sumegi M., Hunyadi-Gulyas E., Medzihradszky K.F., and Udvardy A. 26S proteasome subunits are O-linked N-acetylglucosamine-modified in Drosophila melanogaster. Biochem. Biophys. Res. Commun. 312 (2003) 1284-1289
168. Zachara N.E., and Hart G.W. O-GlcNAc modification: a nutritional sensor that modulates proteasome function. Trends Cell Biol. 14 (2004) 218-221
169. Zhang F., Hu Y., Huang P., Toleman C.A., Paterson A.J., and Kudlow J.E. Proteasome function is regulated by cyclic AMP-dependent protein kinase through phosphorylation of Rpt6. J. Biol. Chem. 282 (2007) 22460-22471
170. Zhang F., Su K., Yang X., Bowe D.B., Paterson A.J., and Kudlow J.E. O-GlcNAc modification is an endogenous inhibitor of the proteasome. Cell 115 (2003) 715-725
171. Jackson S.P., and Tjian R. O-glycosylation of eukaryotic transcription factors: implications for mechanisms of transcriptional regulation. Cell 55 (1988) 125-133
172. Jackson S.P., and Tjian R. Purification and analysis of RNA polymerase II transcription factors by using wheat germ agglutinin affinity chromatography. Proc. Natl. Acad. Sci. USA 86 (1989) 1781-1785
173. Kelly W.G., and Hart G.W. Glycosylation of chromosomal proteins: localization of O-linked N-acetylglucosamine in Drosophila chromatin. Cell 57 (1989) 243-251
174. Comer F.I., and Hart G.W. Reciprocity between O-GlcNAc and O-phosphate on the carboxyl terminal domain of RNA polymerase II. Biochemistry 40 (2001) 7845-7852
175. Comer F.I., Vosseller K., Wells L., Accavitti M.A., and Hart G.W. Characterization of a mouse monoclonal antibody specific for O-linked N-acetylglucosamine. Anal. Biochem. 293 (2001) 169-177
176. Kelly W.G., Dahmus M.E., and Hart G.W. RNA polymerase II is a glycoprotein. Modification of the COOH-terminal domain by O-GlcNAc. J. Biol. Chem. 268 (1993) 10416-10424
177. Kim S.H., Kim Y.H., Song M., An S.H., Byun H.Y., Heo K., Lim S., Oh Y.S., Ryu S.H., and Suh P.G. O-GlcNAc modification modulates the expression of osteocalcin via OSE2 and Runx2. Biochem. Biophys. Res. Commun. 362 (2007) 325-329
178. Okuyama R., and Marshall S. Potential regulation of nuclear UDP-N-acetylglucosaminyl transferase (OGT) by substrate availability: ability of chromatin protein to bind UDP-N-acetylglucosamine and reduce OGT-mediated O-Linked glycosylation. Biol. Pharm. Bull. 27 (2004) 1293-1296
179. Reason A.J., Morris H.R., Panico M., Marais R., Treisman R.H., Haltiwanger R.S., Hart G.W., Kelly W.G., and Dell A. Localization of O-GlcNAc modification on the serum response transcription factor. J. Biol. Chem. 267 (1992) 16911-16921
180. Yang X., Su K., Roos M.D., Chang Q., Paterson A.J., and Kudlow J.E. O-linkage of N-acetylglucosamine to Sp1 activation domain inhibits its transcriptional capability. Proc. Natl. Acad. Sci. USA 98 (2001) 6611-6616
181. Yao D., Taguchi T., Matsumura T., Pestell R., Edelstein D., Giardino I., Suske G., Ahmed N., Thornalley P.J., Sarthy V.P., Hammes H.P., and Brownlee M. Methylglyoxal modification of mSin3A links glycolysis to angiopoietin-2 transcription. Cell 124 (2006) 275-286
182. Mendjan S., and Akhtar A. The right dose for every sex. Chromosoma 116 (2007) 95-106
183. Miller M.W., and Hanover J.A. Functional nuclear pores reconstituted with beta 1-4 galactose-modified O-linked N-acetylglucosamine glycoproteins. J. Biol. Chem. 269 (1994) 9289-9297
184. Duverger E., Roche A.C., and Monsigny M. N-acetylglucosamine-dependent nuclear import of neoglycoproteins. Glycobiology 6 (1996) 381-386
185. Guinez C., Morelle W., Michalski J.C., and Lefebvre T. O-GlcNAc glycosylation: a signal for the nuclear transport of cytosolic proteins?. Int. J. Biochem. Cell Biol. 37 (2005) 765-774
186. Park J., Han D., Kim K., Kang Y., and Kim Y. O-GlcNAcylation disrupts glyceraldehyde-3-phosphate dehydrogenase homo-tetramer formation and mediates its nuclear translocation. Biochim. Biophys. Acta 1794 (2009) 254-262
187. Kornfeld R. Studies on l-glutamine d-fructose 6-phosphate amidotransferase. I. Feedback inhibition by uridine diphosphate-N-acetylglucosamine. J. Biol. Chem. 242 (1967) 3135-3141
188. Shen A., Kamp H.D., Grundling A., and Higgins D.E. A bifunctional O-GlcNAc transferase governs flagellar motility through anti-repression. Genes Dev. 20 (2006) 3283-3295